TWST Twist Bioscience Corporation
Healthcare$64.93+0.00%OpenMarket Cap: $4.04B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$64.40
Target (Median)
$65.00
Target Range
$52.00 - $80.00
Upside from current price: -0.8%
Rating Distribution
1 Strong Buy8 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | Leerink Partners | upgrade | Outperform | Market Perform |
| 2026-05-05 | Barclays | maintain | Overweight | Overweight |
| 2026-05-05 | Baird | maintain | Outperform | Outperform |
| 2026-05-05 | Guggenheim | maintain | Buy | Buy |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-03-30 | Guggenheim | maintain | Buy | Buy |
| 2026-02-03 | Barclays | maintain | Overweight | Overweight |
| 2026-02-03 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-01-26 | Guggenheim | maintain | Buy | Buy |
| 2026-01-08 | TD Cowen | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $-1.37 | $518.7M | 4 |
| Sat Sep 30 | $-0.98 | $596.5M | 7 |
| Sun Sep 30 | $0.65 | $677.3M | 2 |
| Mon Sep 30 | $1.42 | $778.9M | 5 |